{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-011142","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.385533+00:00","generated_at":"2026-06-13T23:49:29.045900+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Iradimed shareholders elect all five director nominees, approve equity plan and charter amendment","bullets":["Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel, James Hawkins elected to board (vote ranges: 7.9M-10.9M for).","Ratified RSM US LLP as auditor for FY2023 (11,617,623 for, 8,816 against).","Advisory say-on-pay approved (10,782,715 for, 133,595 against).","Approved 2023 Equity Incentive Plan (8,665,347 for, 2,251,481 against).","Approved charter amendment limiting officer liability (10,139,697 for, 779,087 against)."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-011142","json":"https://secwatch.observer/filing/0001558370-23-011142.json","markdown":"https://secwatch.observer/filing/0001558370-23-011142.md","text":"https://secwatch.observer/filing/0001558370-23-011142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/irmd-20230615x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T23:49:29.045900+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"27dee7e79b0f6a556eabf185fc4c113a5b2a4426","claim":"IRADIMED CORP shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation at the 2023-06-15 meeting.","evidence_excerpt":"Stockholders voted, on an advisory basis, on the frequency of future advisory votes on executive compensation.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay frequency"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"5a645b455691845cc41a6e6e039a7be6e45115df","claim":"IRADIMED CORP shareholders approved Advisory resolution on the compensation of Iradimed's named executive officers at the 2023-06-15 meeting.","evidence_excerpt":"Stockholders approved an advisory resolution on the compensation of Iradimed's named executive officers.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"78336c653c2cb4bb72ab6bb95e59c2422295531b","claim":"IRADIMED CORP shareholders approved Election of Directors at the 2023-06-15 meeting.","evidence_excerpt":"Stockholders elected each of Roger Susi, Monty Allen, Anthony Vuoto, Hilda Scharen-Guivel and James Hawkins to Iradimed's Board of Directors, each to hold office until a succeeding annual meeting of stockholders or until such director's successor shall have been duly elected and qualified (or, if earlier, such director's removal or resignation from our Board), as set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"ea64918c20a8d12442a5100f5f28beaa37f43a00","claim":"IRADIMED CORP shareholders approved Amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company at the 2023-06-15 meeting.","evidence_excerpt":"Stockholders approved an amendment to our Restated Certificate of Incorporation to limit the liability of certain officers of the Company.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"ed7bd1a43105f01374529a3ce873b9b061f2589a","claim":"IRADIMED CORP shareholders approved Approval of the Iradimed Corporation 2023 Equity Incentive Plan at the 2023-06-15 meeting.","evidence_excerpt":"Stockholders approved the Iradimed Corporation 2023 Equity Incentive Plan.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"},{"claim_id":"f12db74cfd14f6f1a1c34259f266281a281691cf","claim":"IRADIMED CORP shareholders approved Ratification of the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2023 at the 2023-06-15 meeting.","evidence_excerpt":"Stockholders ratified the selection of RSM US LLP as Iradimed's independent registered public accounting firm to perform independent audit services for the fiscal year ending December 31, 2023, as set forth below.","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000155837023011142/0001558370-23-011142-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}